These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 6921785)
21. Protection of human subjects. United States Code Fed Regul Shipping; 1982 Oct; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819 [No Abstract] [Full Text] [Related]
22. FDA seeks tighter controls over research with human subjects. Hershey N; Miller RD Hosp Med Staff; 1978 Dec; 7(12):1-7. PubMed ID: 10239337 [TBL] [Abstract][Full Text] [Related]
23. An IRB member's perspective on access to innovative therapy. Moore DL Albany Law Rev; 1994; 57(3):559-81. PubMed ID: 11652854 [No Abstract] [Full Text] [Related]
24. Rate of refusal to participate in clinical trials. Shimm DS; Spece RG IRB; 1992; 14(2):7-9. PubMed ID: 11651246 [No Abstract] [Full Text] [Related]
25. Do we need another advisory commission on human experimentation? Katz J Hastings Cent Rep; 1995; 25(1):29-31. PubMed ID: 7730048 [No Abstract] [Full Text] [Related]
26. Putting the "ethics" into "research ethics". Spike J Am J Bioeth; 2005; 5(1):51-3; author reply W15-8. PubMed ID: 16036663 [No Abstract] [Full Text] [Related]
27. Judging the ethical merit of clinical trials: what criteria do research ethics board members use? Meslin EM; Lavery JV; Sutherland HJ; Till JE IRB; 1994; 16(4):6-10. PubMed ID: 11654136 [No Abstract] [Full Text] [Related]
28. Beyond respect for persons and beneficence: justice in research. Lebacqz KA IRB; 1980; 2(7):1-4. PubMed ID: 11663082 [No Abstract] [Full Text] [Related]
29. Dilemmas in paying for clinical research: the view from the IRB. Lind SE IRB; 1987; 9(2):1-5. PubMed ID: 11649900 [No Abstract] [Full Text] [Related]
30. Ethics of drug experimentation. Sgreccia E Dolentium Hominum; 1987; 4(2nd Yr. 1):60-75. PubMed ID: 11653200 [No Abstract] [Full Text] [Related]
31. Justice and research design: the case for a semi-randomization clinical trial. Veatch RM Clin Res; 1983 Feb; 31(1):12-22. PubMed ID: 10299203 [No Abstract] [Full Text] [Related]
33. The ethical approach to randomization in oncology. Arpaillange P; Dion S Drugs Exp Clin Res; 1986; 12(1-2-3):99-103. PubMed ID: 11650154 [No Abstract] [Full Text] [Related]
34. Coercion in the recruitment and retention of human research subjects, pharmaceutical industry payments to physician-investigators, and the moral courage of the IRB. DeRenzo EG IRB; 2000; 22(2):1-5. PubMed ID: 11883465 [No Abstract] [Full Text] [Related]
35. Some questionable premises about research ethics. Macklin R Am J Bioeth; 2005; 5(1):29-31; author reply W15-8. PubMed ID: 16036652 [No Abstract] [Full Text] [Related]
36. Which subjects should an IRB protect? Two moral models. Lackey DP IRB; 1982; 4(7):5-6. PubMed ID: 11651703 [No Abstract] [Full Text] [Related]
37. Limits to the right of privacy: reason, not rhetoric--response. Veatch RM IRB; 1982 Apr; 4(4):5-7. PubMed ID: 11649406 [No Abstract] [Full Text] [Related]
38. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials. Weijer C IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912 [No Abstract] [Full Text] [Related]
39. On studying the powerful (or fearing to do so): a vital role for IRBs. Sieber JE IRB; 1989; 11(5):1-6. PubMed ID: 11650252 [No Abstract] [Full Text] [Related]